Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study
Journal article published in 2018 by
W. Sheridan William Sheridan William P. Sheridan Wp Sheridan,
Marc A. Riedl 
,
E. Aygören-Pürsün,
J. Baker,
Henriette Farkas ,
J. Anderson,
Jonathan A. Bernstein ,
Laurence Bouillet ,
P. Busse,
M. Manning,
M. Magerl ,
M. Gompels,
Huissoon Ap,
A. P. Huissoon,
H. Longhurst
and other authors.
,
E. Aygören-Pürsün,
J. Baker,
Henriette Farkas ,
J. Anderson,
Jonathan A. Bernstein ,
Laurence Bouillet ,
P. Busse,
M. Manning,
M. Magerl ,
M. Gompels,
Huissoon Ap,
A. P. Huissoon,
H. Longhurst
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 